Sensitivity | Specificity | |
Manger et al 201249 | 0.78 | NA |
Wu et al 201498 | 0.97 | 0.87 |
HJ et al 201599 | 0.91 | 0.85 |
Huppertz et al 201477 | 0.78 | 0.93 |
Dalbeth et al 201540 | ||
Early disease (≤3 years) | 0.79 | NA |
Late disease (>3 years) | 0.84 | NA |
Ahmad et al 2016100 | 0.82 | 0.89 |
Kiefer et al 2016101 | 0.71 | 0.95 |
Ogdie et al 201543MA* | 0.87 (0.79–0.93) | 0.84 (0.75–0.90) |
Lee and Song 2017102MA† | 0.84 (0.81–0.87) | 0.93 (0.93–0.96) |
Diagnosis of gout, clinical classification criteria only98–101; MSU crystal identification only40 50 103 104; clinical criteria and/or MSU crystal identification.49 77
*Pooled data from: 50 103 104
†50 77 98–101 103 104
DECT, dual-energy CT; MA, meta-analysis; MSU, monosodium urate; NA, not applicable.